Boston Scientific Corporation has announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The SYNERGY Stent uses a bioabsorbable PLGA polymer and everolimus drug formulation to create a thin, uniform coating confined to the outer surface of the stent. Once the drug has been delivered, the bioabsorbable coating resorbs into the body, leaving behind only a bare-metal stent.

Read the full story here

BabyCenter®, moms’ most trusted parenting and pregnancy site, announced the launch of the BabyCenter® My Pregnancy application for iPhone and iPod touch. This new, free application guides expectant moms through their pregnancy journey, offering award-winning, medically reviewed health content; advice from obstetricians, midwives, nutritionists, and other experts; daily activities and reminders; and conversation and connection with other moms-to-be in BabyCenter’s community.

Read the full story here

Advanced Cell Diagnostics, Inc. (ACD) announces the launch and immediate availability of RNAscope™ FFPE Assay Kit, a line of RUO (Research-Use-Only) products designed to detect RNA biomarkers in routine Formalin-Fixed, Paraffin-Embedded (FFPE) tissue specimens with single molecule sensitivity. The products are intended to be used by translational clinical researchers studying biomarkers in disease tissues and exploring their potential for diagnostic applications. It is a robust and standardized manual assay in ready-to-use format.

Read the full story here

AdvanDx announced the launch of its CE-IVD marked GNR Traffic Light™ PNA FISH® test in Europe. GNR Traffic Light PNA FISH is the first-ever test capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from positive blood cultures in less than 90 minutes. The GNR Traffic Light is the latest addition to AdvanDx’s easy-to-use, molecular-based PNA FISH diagnostics platform designed to provide rapid, therapy-guiding results.

Read the full story here

Scottsdale Healthcare is testing a new under-the-skin device that uses an electrical shock to interrupt possibly fatal heart rhythms, restoring a normal heartbeat for patients at high risk of sudden cardiac arrest. The first Arizona patient received the device at Scottsdale Healthcare Shea Medical Center. The subcutaneous implantable cardioverter defibrillator uses life-saving electrical impulses under the skin near the heart, instead of placing electrical wires through veins to access the heart used in conventional methods.

Read the full story here

Codman & Shurtleff, Inc. has announced the launch of the stretch resistant XTRASOFT™ ORBIT GALAXY™ Coil (XTRASOFT), the softest endovascular finishing coil1 for use in the treatment of cerebral aneurysms. XTRASOFT is the first in a family of coils known as the ORBIT GALAXY™ Detachable Coil System, Codman’s next generation, stretch resistant coil platform. The announcement was made here at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting.

Read the full story here

Researchers in the UK have developed an implantable sensor that measures blood glucose levels continuously and transmits the information wirelessly. The sensor, however, has so far only been tested in pigs. The small, round device is being touted as having the potential to overhaul the way people with diabetes control their condition. The sealed unit has a pair of sensors and the researchers claim it could be implanted in a person’s torso with one sensor.

Read the full story here

Hotspur Technologies, Inc. has announced that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur’s unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients. These new Hotspur devices are focused on solving some of the key challenges resulting from two types of medical procedures for restoring bloodflow.

Read the full story here